On the basis of the ROC curves, a serum MST1 concentration of 398.50 μg/ml was selected as the optimal cutoff value for differentiating CRC patients and controls, with a sensitivity of 82.4% and specificity of 93.8%, respectively. The gene discussed is MST1; the disease is colorectal carcinoma.